EDAP Announces First Published Long-Term Study of HIFU for Localized Prostate Cancer LYON, France, Dec. 13, 2007 (PRIME NEWSWIRE) -- EDAP TMS S.A. (Nasdaq:EDAP) the global leader in High Intensity Focused Ultrasound treatment of prostate cancer announces the release of the first multi-center
EDAP Announces Third Quarter Results Conference Call LYON, France, Nov. 14, 2007 (PRIME NEWSWIRE) -- EDAP TMS S.A. (Nasdaq:EDAP) the global leader in High Intensity Focused Ultrasound treatment of prostate cancer, announced it will release its third quarter 2007 financial results Monday, November
EDAP Launches Ablatherm-HIFU RPP Service At First South African Site LYON, France, Nov. 8, 2007 (PRIME NEWSWIRE) -- EDAP TMS S.A. (Nasdaq:EDAP) the global leader in High Intensity Focused Ultrasound treatment of prostate cancer announces, together with their South African distributors, Intamed, the
EDAP TMS S.A. Announces $20 Million Placement to Fund US Clinical Studies LYON, France , Oct. 30 /PRNewswire-FirstCall/ -- EDAP TMS S.A. (Nasdaq: EDAP) the global leader in High Intensity Focused Ultrasound treatment of prostate cancer announces that it has entered into a securities purchase
EDAP TMS S.A. to Participate in German Conference, Updates Growth Outlook Lyon, France, September 19, 2006 - EDAP TMS S.A. (Nasdaq: EDAP) , the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer, announced a series of events centered around the DGU Conference in